Related Experiment Video
Updated: Dec 20, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Reactive Arthritis: Treatment Challenges and Future Perspectives
Daniel Wendling1,2, Clément Prati3,4, Mickael Chouk3
1Department of Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030, Besançon, France. dwendling@chu-besancon.fr.
Purpose Of The Review:
Reactive arthritis is synovitis related to an infection away from the joint. The evolution is variable, frequently self-limited, but with the possible evolution to a prolonged form, generating functional incapacity and sequelae.
Recent Findings:
New microbiological families have been incriminated and pathophysiological links have been clarified, highlighting the role of the mucous membranes (gut in particular), specific cell populations, and the production of pro-inflammatory cytokines. First-line pharmacological treatment is based on NSAIDs. In case of failure, synthetic and more recently biological DMARDs are indicated. Only open data are available for biological DMARDs but suggest good efficacy and safety. Reactive arthritis has not disappeared. The diagnosis must be mentioned by the clinic and history to allow the rapid introduction of an appropriate treatment.
Insights
Reactive arthritis, an infection-related synovitis, can lead to long-term disability. Early diagnosis and treatment with NSAIDs or DMARDs are crucial for managing this condition.
Area of Science:
- Rheumatology
- Immunology
- Microbiology
Background:
- Reactive arthritis is characterized by synovitis secondary to a distant infection.
- Its clinical course is variable, ranging from self-limited episodes to chronic forms with functional impairment and sequelae.
Purpose of the Study:
- To review recent findings in reactive arthritis, including etiological agents and pathophysiological mechanisms.
- To discuss current and emerging treatment strategies for reactive arthritis.
Main Methods:
- Literature review of microbiological and immunological studies.
- Analysis of clinical data on treatment outcomes for reactive arthritis.
Main Results:
- New microbiological agents have been implicated in reactive arthritis.
- Pathophysiological insights highlight the role of mucosal immunity, specific cell populations, and pro-inflammatory cytokines.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are first-line treatments; synthetic and biological disease-modifying antirheumatic drugs (DMARDs) are used for refractory cases.
- Available data suggest biological DMARDs offer good efficacy and safety.
Conclusions:
- Reactive arthritis remains a significant clinical challenge.
- Prompt diagnosis based on clinical presentation and history is essential for timely and appropriate treatment initiation.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

